Canada markets closed

NLS Pharmaceutics Ltd. (NLSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.1360+0.0021 (+1.57%)
At close: 04:00PM EDT
0.1392 +0.00 (+2.35%)
After hours: 04:12PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
8,948
5,431
93.711
Total Cash
8,948
5,431
93.711
Total Current Assets
9,246
5,723
196.711
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
39.56
39.56
0
Accumulated Depreciation
-21.458
-10.05
0
Net property, plant and equipment
18.102
29.51
0
Other long-term assets
12.143
12.044
-
Total non-current assets
30.245
41.554
1,015
Total Assets
9,277
5,765
1,212
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
-
1,771
Accounts Payable
2,373
1,737
4,006
Accrued liabilities
471.652
659.572
1,355
Total Current Liabilities
3,360
2,403
7,204
Non-current liabilities
Long Term Debt
-
-
313.478
Deferred revenues
2,500
2,500
2,500
Total non-current liabilities
2,636
2,819
2,992
Total Liabilities
5,996
5,222
10,196
Stockholders' Equity
Common Stock
668.555
344.445
145.139
Retained Earnings
-58,201
-41,706
-29,760
Accumulated other comprehensive income
-50.791
-151.739
-19.381
Total stockholders' equity
3,281
542.388
-8,984
Total liabilities and stockholders' equity
9,277
5,765
1,212